JP2006075152A5 - - Google Patents

Download PDF

Info

Publication number
JP2006075152A5
JP2006075152A5 JP2005225206A JP2005225206A JP2006075152A5 JP 2006075152 A5 JP2006075152 A5 JP 2006075152A5 JP 2005225206 A JP2005225206 A JP 2005225206A JP 2005225206 A JP2005225206 A JP 2005225206A JP 2006075152 A5 JP2006075152 A5 JP 2006075152A5
Authority
JP
Japan
Prior art keywords
gene
cell
astroglial
migration
cell migration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2005225206A
Other languages
Japanese (ja)
Other versions
JP2006075152A (en
Filing date
Publication date
Application filed filed Critical
Priority to JP2005225206A priority Critical patent/JP2006075152A/en
Priority claimed from JP2005225206A external-priority patent/JP2006075152A/en
Publication of JP2006075152A publication Critical patent/JP2006075152A/en
Publication of JP2006075152A5 publication Critical patent/JP2006075152A5/ja
Pending legal-status Critical Current

Links

Claims (9)

Lib遺伝子の発現を阻害することおよび/または該遺伝子によりコードされる蛋白質の機能を阻害することを特徴とする、ヒト生体内を除くアストログリア細胞の移動阻害方法。 A method for inhibiting migration of astroglial cells excluding human in vivo, which comprises inhibiting expression of a Lib gene and / or inhibiting a function of a protein encoded by the gene. Lib遺伝子の発現阻害剤および/または該遺伝子によりコードされる蛋白質の機能阻害剤を用いることを特徴とする、ヒト生体内を除くアストログリア細胞の移動阻害方法。 A method for inhibiting the migration of astroglial cells excluding human in vivo, comprising using an expression inhibitor of Lib gene and / or a function inhibitor of a protein encoded by the gene. Lib遺伝子のアンチセンスポリヌクレオチドを用いることを特徴とする、ヒト生体内を除くアストログリア細胞の移動阻害方法。 A method for inhibiting migration of astroglial cells excluding human living bodies, comprising using an antisense polynucleotide of a Lib gene. Lib遺伝子の発現を阻害するsiRNAまたはshRNAを用いることを特徴とする、ヒト生体内を除くアストログリア細胞の移動阻害方法。 A method for inhibiting migration of astroglial cells excluding human living bodies, comprising using siRNA or shRNA that inhibits expression of a Lib gene. Lib遺伝子によりコードされる蛋白質のアストログリア細胞の細胞移動能を阻害する化合物の同定方法であって、Lib遺伝子を発現している細胞とある化合物(被検化合物)との相互作用を可能にする条件下で該細胞と被検化合物とを接触させ、次いで、該細胞の移動を測定することのできる条件下で細胞の移動を測定し、被検化合物の存在下における該細胞の移動と被検化合物の非存在下における該細胞の移動とを比較し、該細胞の移動の変化を検出することにより、被検化合物がLib遺伝子によりコードされる蛋白質の細胞移動能を阻害するか否かを判定することを特徴とする同定方法。 A method for identifying a compound that inhibits the cell migration ability of an astroglial cell of a protein encoded by a Lib gene, which enables interaction between a cell expressing the Lib gene and a certain compound (test compound) The cell is contacted with the test compound under conditions, and then the cell migration is measured under conditions where the cell migration can be measured, and the cell migration and test in the presence of the test compound are measured. By comparing the movement of the cell in the absence of the compound and detecting a change in the movement of the cell, it is determined whether the test compound inhibits the cell migration ability of the protein encoded by the Lib gene. The identification method characterized by doing. Lib遺伝子のアンチセンスポリヌクレオチドを有効量含んでなるアストログリア細胞の移動阻害剤。 An astroglial cell migration inhibitor comprising an effective amount of an antisense polynucleotide of the Lib gene. Lib遺伝子の発現を阻害するsiRNAまたはshRNAを有効量含んでなるアストログリア細胞の移動阻害剤。 An astroglial cell migration inhibitor comprising an effective amount of siRNA or shRNA that inhibits expression of the Lib gene. 配列表の配列番号1に記載の塩基配列に相補的な塩基配列または該相補的な塩基配列の一部を含有するアンチセンスポリヌクレオチドを有効量含んでなるアストログリア細胞の移動阻害剤。 A astroglial cell migration inhibitor comprising an effective amount of an antisense polynucleotide containing a base sequence complementary to the base sequence set forth in SEQ ID NO: 1 in the Sequence Listing or a part of the complementary base sequence. 配列表の配列番号1に記載の塩基配列からなるLib遺伝子の発現を阻害するsiRNAまたはshRNAを有効量含んでなるアストログリア細胞の移動阻害剤。 An astroglial cell migration inhibitor comprising an effective amount of siRNA or shRNA that inhibits expression of a Lib gene comprising the base sequence set forth in SEQ ID NO: 1 in the Sequence Listing.
JP2005225206A 2004-08-09 2005-08-03 Cell movement inhibitor Pending JP2006075152A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2005225206A JP2006075152A (en) 2004-08-09 2005-08-03 Cell movement inhibitor

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004232755 2004-08-09
JP2005225206A JP2006075152A (en) 2004-08-09 2005-08-03 Cell movement inhibitor

Publications (2)

Publication Number Publication Date
JP2006075152A JP2006075152A (en) 2006-03-23
JP2006075152A5 true JP2006075152A5 (en) 2008-09-04

Family

ID=36155121

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2005225206A Pending JP2006075152A (en) 2004-08-09 2005-08-03 Cell movement inhibitor

Country Status (1)

Country Link
JP (1) JP2006075152A (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003164290A (en) * 2001-11-30 2003-06-10 Dai Ichi Seiyaku Co Ltd beta-AMYLOID-INDUCING Lib GENE
JP4531482B2 (en) * 2004-08-10 2010-08-25 第一三共株式会社 β-amyloid-induced Mib gene

Similar Documents

Publication Publication Date Title
JP2010207229A5 (en)
JP2010521655A5 (en)
WO2009132058A3 (en) Levels of bcma protein expression on b cells and use in diagnostic methods
JP2007506426A5 (en)
RU2012148125A (en) BIOMARKERS BASED ON A MULTIRACER ASSOCIATED WITH INVASION MECHANISM
WO2012075506A3 (en) Methods for predicting and treating infection-induced illnesses and predicting the severity of infection-induced illnesses
JP2011525106A5 (en)
WO2008044032A3 (en) T cell epitope databases
JP2011037847A5 (en)
WO2008141282A3 (en) Materials and methods for foxp3 tumor suppression
WO2006012468A3 (en) Detection of oligonuleotides by dual hybridization
MX2010000031A (en) Detection of micro-organisms based on their nad-dependent dna ligase activity.
RU2016119726A (en) The method of conducting a test for the dissolution of solid compositions containing digestive enzymes
JP2015504299A5 (en)
JP2009517381A5 (en)
ATE545033T1 (en) DIAGNOSTIC METHODS FOR HIV INFECTION
WO2008034622A3 (en) A method of detecting and/or quantifying expression of a target protein candidate in a cell, and a method of identifying a target protein of a small molecule modulator
JP2011518338A5 (en)
WO2008029290A3 (en) Identification of cancer stem cells using genetic markers
WO2015048804A3 (en) Protein biomarker and uses thereof
JP2018504909A5 (en)
JP2006075152A5 (en)
WO2010035259A3 (en) Compositions comprising soluble cd84 or anti-cd84 antibodies and methods for diagnosing and treating b-cll
CN105929001B (en) The gold electrode and preparation method and application of specific DNA pseudoknot structure modification
WO2007107370A8 (en) Cytokine-based pyrogen test